Sydbank Says Novo Nordisk Results Exceeded Expectations, Guidance Raised
Sydbank senior analyst Soren Lontoft Hansen says Novo Nordisk’s underlying performance was better than expected and its guidance revision exceeded expectations.
Novo Nordisk's financial results are highly positive overall, with an underlying performance that is clearly better than expected and an upward revision to guidance that exceeds expectations, Sydbank's senior analyst Soren Lontoft Hansen writes. "Novo delivered positive growth rates in the third qu…